Precision Medicine in Cardiology: Identifying Risk Before Disease Develops
Discover how genomics, biomarkers, and precision cardiology help identify cardiovascular risk early and enable personalized prevention.
Case Study: Using Genomic Data to Guide Treatment Decisions
Learn how genomic profiling identified an EGFR mutation and guided targeted therapy selection in a real-world precision oncology case.
Pharmacogenomics in Clinical Practice: Prescribing the Right Drug the First Time
Helping clinicians understand how genetic variation influences drug response
How Biomarker-Guided Medicine Is Changing Everyday Clinical Care
Advances in biomedical research have significantly expanded the role of molecular and physiological indicators in clinical decision-making. Among the most influential of these developments is the increasing use of biomarkers to guide diagnosis, risk assessment, treatment selection, and disease monitoring. Biomarker-guided medicine represents a core component of precision medicine, emphasizing the use of measurable biological signals to inform individualized clinical care.
A multidisciplinary community committed to advancing research, education, and clinical standards in precision medicine.
FOLLOW US
LEARN ABOUT THE
ABOPM
CUSTOMER CARE
LEGAL
Copyright 2026. American Board of Precision Medicine. All Rights Reserved.